Omnicef and Sepsis - a phase IV clinical study of FDA data

Summary:

Sepsis is reported as a side effect among people who take Omnicef (cefdinir), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Myelodysplastic syndrome.

The phase IV clinical study analyzes which people have Sepsis when taking Omnicef. It is created by eHealthMe based on reports of 2,586 people who have side effects when taking Omnicef from the FDA, and is updated regularly.

What is Omnicef?

Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.

What is Sepsis?

Sepsis (a severe blood infection that can lead to organ failure and death) is found to be associated with 2,525 drugs and 3,260 conditions by eHealthMe. Check the latest studies of Sepsis.

On Aug, 05, 2026

2,586 people reported to have side effects when taking Omnicef.
Among them, 19 people (0.73%) have Sepsis.

Among these 19 people:

How long have people been on Omnicef when they have Sepsis? *

What is the gender of people who have Sepsis when taking Omnicef? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Sepsis when taking Omnicef? *

What are other drugs people take besides Omnicef? *

What are other side effects people have besides Sepsis? *

Hypotension (abnormally low blood pressure): 9 people, 47.37%
Pneumonia: 6 people, 31.58%
Fever: 6 people, 31.58%
Acute Kidney Failure: 5 people, 26.32%
Urinary Tract Infection: 5 people, 26.32%
Thrombocytopenia (decrease of platelets in blood): 5 people, 26.32%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 26.32%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 21.05%
Anaemia (lack of blood): 4 people, 21.05%
Headache (pain in head): 4 people, 21.05%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 15.79%
Thyroid Cancer: 1 person, 5.26%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.26%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 5.26%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 1 person, 5.26%
Drowsiness: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 5.26%
Nausea (feeling of having an urge to vomit): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Omnicef and have Sepsis?

- Check whether Sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omnicef:

Omnicef (2,774 reports)

Sepsis treatments and more:

Sepsis (140,102 reports)

Browse all side effects of Omnicef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sepsis:

Sepsis (2,525 drugs)

Browse all the conditions that are associated with Sepsis:

Sepsis (3,260 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir (the active ingredients of Omnicef) and Omnicef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.